Literature DB >> 19662604

Neutrophil degranulation in antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis.

Fang Wang1, Min Chen, Ming-Hui Zhao.   

Abstract

BACKGROUND: Patients with pauci-immune crescentic glomerulonephritis (CrGN) are frequently found to have antineutrophil cytoplasmic antibodies (ANCAs). It has been demonstrated that ANCAs can induce neutrophil activation and degranulation, which plays an important role in the pathogenesis of ANCA-associated vasculitis. However, the pathogenesis of ANCA-negative pauci-immune CrGN is not clear. This study aims to investigate the evidence for neutrophil activation and degranulation at disease presentation in patients with renal biopsy-proven ANCA-negative pauci-immune CrGN.
METHODS: Sera from 20 patients with ANCA-negative pauci-immune CrGN and 22 patients with ANCA-positive pauci-immune CrGN were collected at presentation. Serum neutrophil gelatinase-associated lipocalin (NGAL) and lactoferrin (LF) were measured using commercial ELISA kits.
RESULTS: Serum levels of NGAL in ANCA-negative patients were significantly higher than those of ANCA-positive patients (940.8 +/- 676.5 ng/mL vs. 569.3 +/- 287.2 ng/mL, p<0.05). This was still the case after adjustment for renal function. Serum levels of LF in ANCA-negative patients were also significantly higher than those of ANCA-positive patients (24.92 +/- 6.13 U/mL vs. 18.48 +/- 6.89 U/mL, p<0.05).
CONCLUSION: Neutrophil activation and degranulation occurs in patients with ANCA-negative pauci-immune CrGN in the absence of ANCA, and might be even more prominent than in their ANCA-positive counterparts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19662604

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  8 in total

Review 1.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

2.  A case of MPO- and PR3-ANCA-negative pauci-immune renal-limited small-vessel vasculitis associated with endometrial neuroendocrine small cell carcinoma.

Authors:  Shuzo Kaneko; Yusuke Tsukamoto; Kazuya Abe; Masayuki Yonamine; Sumiko Hasegawa; Hiromi Hikida
Journal:  CEN Case Rep       Date:  2013-01-26

3.  Pauci-immune lupus nephritis: possibility or co-incidence?

Authors:  Döndü Üsküdar Cansu; Gökhan Temiz; Mustafa F Açıkalın; Cengiz Korkmaz
Journal:  Eur J Rheumatol       Date:  2017-03-01

Review 4.  The Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China.

Authors:  Zhi-Ying Li; Tian-Tian Ma; Min Chen; Ming-Hui Zhao
Journal:  Kidney Dis (Basel)       Date:  2015-12-09

5.  Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Guang-qun Xing; Min Chen; Gang Liu; Xin Zheng; Jie E; Ming-hui Zhao
Journal:  J Clin Immunol       Date:  2009-11-07       Impact factor: 8.317

6.  Pulmonary renal syndrome: A case report of diffuse alveolar hemorrhage in association with ANCA negative pauci-immune glomerulonephritis.

Authors:  Lakshmi Saladi; Danial Shaikh; Muhammad Saad; Enny Cancio-Rodriguez; Vivette D D'Agati; Boris Medvedovsky; Kalpana A Uday; Muhammad Adrish
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 7.  Narrative Review of Hypercoagulability in Small-Vessel Vasculitis.

Authors:  Sophie E Claudel; Bryan M Tucker; Daniel T Kleven; James L Pirkle; Mariana Murea
Journal:  Kidney Int Rep       Date:  2020-01-13

8.  Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report.

Authors:  Xiao-Li Li; Peng-Cheng Xu; Tong Chen; Tie-Kun Yan; Jian-Qing Jiang; Jun-Ya Jia; Li Wei; Wen-Ya Shang; Shui-Yi Hu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.